Income Statement RAMM Pharma Corp.

Stocks

RAMM

CA75150G1046

Pharmaceuticals

Market Closed - Canadian Securities Exchange 09:31:18 2026-08-21 EDT			5-day change	1st Jan Change
0.0100 ^CAD	0.00%		0.00%	-83.33%

06-30	RAMM Pharma Corp. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2026	CI
04-02	RAMM Pharma Corp. Reports Earnings Results for the First Quarter Ended January 31, 2026	CI

f498e7306132.y7XoJdNJTnZg7p0THOQSO1SqMRIWUKrIBiaLzACBoTc.mfLFHeAuOyUtlPNQddx3dSD7Xl9JHpmeY2Hs-HrH_mOYg4dw4CgKGjSa7g

Published financial data: RAMM PHARMA CORP.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: October	2021	2022	2023	2024	2025
Revenues	4.12M	3.9M	5.07M	4.34M	3.36M
Total Revenues	4.12M	3.9M	5.07M	4.34M	3.36M
Cost of Goods Sold, Total	4.15M	3.41M	4.68M	2.57M	2.51M
Gross Profit	-37.32K	485K	382K	1.78M	849K
Selling General & Admin Expenses, Total	6.6M	8.42M	7.47M	8.42M	5.3M
Provision for Bad Debts	-	-	-	2.18M	-
Depreciation & Amortization - (IS)	-	-	-	-	-
Other Operating Expenses	-	-	-	122K	80.84K
Other Operating Expenses, Total	6.6M	8.42M	7.47M	10.72M	5.38M
Operating Income	-6.64M	-7.94M	-7.09M	-8.94M	-4.53M
Interest Expense, Total	-12.83K	-13.3K	-53.96K	-44.18K	-243K
Interest And Investment Income	374K	163K	196K	33.61K	6.59K
Net Interest Expenses	361K	150K	142K	-10.57K	-237K
Income (Loss) On Equity Invest.	-714K	-	-	-	-
Currency Exchange Gains (Loss)	-298K	75.5K	-42.75K	-4.31K	-74.2K
Other Non Operating Income (Expenses)	28.96K	167K	348K	19.12K	-51.94K
EBT, Excl. Unusual Items	-7.26M	-7.54M	-6.64M	-8.93M	-4.89M
Impairment of Goodwill	-	-12.93M	-	-	-
Gain (Loss) On Sale Of Investments	268K	-227K	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	766K
Asset Writedown	-	-251K	-1.07M	-7.56M	-4.77M
Other Unusual Items	-105K	-	-	-	-
EBT, Incl. Unusual Items	-7.1M	-20.95M	-7.71M	-16.49M	-8.89M
Income Tax Expense	5.56K	8.39K	9.69K	8.12K	15.25K
Earnings From Continuing Operations	-7.11M	-20.96M	-7.72M	-16.5M	-8.91M
Net Income to Company	-7.11M	-20.96M	-7.72M	-16.5M	-8.91M
Net Income - (IS)	-7.11M	-20.96M	-7.72M	-16.5M	-8.91M
Net Income to Common Incl Extra Items	-7.11M	-20.96M	-7.72M	-16.5M	-8.91M
Net Income to Common Excl. Extra Items	-7.11M	-20.96M	-7.72M	-16.5M	-8.91M
Per Share Items
Net EPS - Basic	-0.07	-0.17	-0.06	-0.14	-0.07
Basic EPS - Continuing Operations	-0.07	-0.17	-0.06	-0.14	-0.07
Basic Weighted Average Shares Outstanding	108M	123M	121M	119M	119M
Net EPS - Diluted	-0.07	-0.17	-0.06	-0.14	-0.07
Diluted EPS - Continuing Operations	-0.07	-0.17	-0.06	-0.14	-0.07
Diluted Weighted Average Shares Outstanding	108M	123M	121M	119M	119M
Normalized Basic EPS	-0.04	-0.04	-0.03	-0.05	-0.03
Normalized Diluted EPS	-0.04	-0.04	-0.03	-0.05	-0.03
Supplemental Items
EBITDA	-6.01M	-7M	-6.04M	-7.97M	-3.93M
EBITA	-6.33M	-7.63M	-6.78M	-8.63M	-4.35M
EBIT	-6.64M	-7.94M	-7.09M	-8.94M	-4.53M
EBITDAR	-	-	-	-7.94M	-3.89M
Effective Tax Rate - (Ratio)	-0.08	-0.04	-0.13	-0.05	-0.17
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	5.56K	8.39K	9.69K	8.12K	15.25K
Normalized Net Income	-4.54M	-4.72M	-4.15M	-5.58M	-3.06M
Interest on Long-Term Debt	3.17K	9.77K	49.91K	27.39K	8.59K
Supplemental Operating Expense Items
Advertising Expense	90.8K	420K	200K	62.1K	20.61K
Selling and Marketing Expenses	90.8K	420K	200K	62.1K	20.61K
General and Administrative Expenses	-	-	-	-	-
Net Rental Expense, Total	-	-	-	22.45K	38.96K
Imputed Operating Lease Interest Expense	-	-	-	26.74K	564K
Imputed Operating Lease Depreciation	-	-	-	-4.29K	-525K
Maintenance & Repair Expenses, Total	65.96K	63.01K	67.81K	64.92K	36.97K
Stock-Based Comp., SG&A Exp. (Total)	699K	384K	14.2K	170K	-
Total Stock-Based Compensation	699K	384K	14.2K	170K	-

Fiscal Period: October	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	17.16M	9.77M	5.12M	814K	804K
Total Cash And Short Term Investments	17.16M	9.77M	5.12M	814K	804K
Accounts Receivable, Total	1.17M	978K	616K	785K	447K
Other Receivables	2.78M	1.83M	1.26M	859K	430K
Total Receivables	3.95M	2.81M	1.88M	1.64M	877K
Inventory	3.05M	4.02M	3.14M	2.54M	927K
Prepaid Expenses	63.73K	84.83K	216K	258K	27.46K
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	59.55K	30.62K	240K	102K	3.06K
Total Current Assets	24.28M	16.71M	10.59M	5.36M	2.64M
Gross Property Plant And Equipment	21.06M	22.92M	23.08M	15.86M	11.36M
Accumulated Depreciation	-2.3M	-3.21M	-4.03M	-4.66M	-4.73M
Net Property Plant And Equipment	18.76M	19.71M	19.05M	11.2M	6.63M
Goodwill	13.67M	-	-	-	-
Other Intangibles, Total	1.13M	803K	492K	188K	3.96K
Other Long-Term Assets, Total	1.86M	2.08M	2.17M	-	-
Total Assets	59.71M	39.31M	32.3M	16.75M	9.27M
Liabilities
Accounts Payable, Total	1.93M	1.17M	1.21M	644K	381K
Accrued Expenses, Total	478K	557K	335K	358K	279K
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	29.97K	230K	225K	103K	68.96K
Current Income Taxes Payable	4.8K	6.13K	6.91K	8.02K	-
Other Current Liabilities	872K	1.3M	874K	1.92M	2.83M
Total Current Liabilities	3.32M	3.27M	2.66M	3.03M	3.56M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	2.2K	454K	180K	84.83K	11.43K
Total Liabilities	3.32M	3.72M	2.84M	3.11M	3.57M
Common Stock, Total	63.06M	62.52M	60.99M	60.99M	60.99M
Additional Paid In Capital	1.36M	1.36M	3.05M	6.87M	7.17M
Retained Earnings	-22.44M	-43.09M	-49.45M	-65.91M	-74.82M
Comprehensive Income and Other	14.42M	14.79M	14.88M	11.69M	12.36M
Total Common Equity	56.39M	35.59M	29.46M	13.63M	5.7M
Total Equity	56.39M	35.59M	29.46M	13.63M	5.7M
Total Liabilities And Equity	59.71M	39.31M	32.3M	16.75M	9.27M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	123M	122M	119M	119M	119M
ECS Total Common Shares Outstanding	123M	122M	119M	119M	119M
Book Value / Share	0.46	0.29	0.25	0.11	0.05
Tangible Book Value	41.59M	34.78M	28.97M	13.45M	5.69M
Tangible Book Value Per Share	0.34	0.28	0.24	0.11	0.05
Total Debt	32.16K	684K	405K	188K	80.39K
Net Debt	-17.12M	-9.09M	-4.71M	-626K	-723K
Debt Equivalent Oper. Leases	-	-	-	180K	312K
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	2.88M	3.45M	4.23M	3.78M	3.51M
Inventories - Finished Goods, Total	1.04M	1.71M	1.27M	1.16M	783K
Land - (BS)	3.84M	4.42M	4.58M	3.7M	2.48M
Machinery, Total	5.02M	5.82M	6.06M	5.66M	5.5M
Accumulated Allowance for Doubtful Accounts (Supple)	232K	145K	149K	90.45K	108K

Fiscal Period: October	2021	2022	2023	2024	2025
Net Income	-7.11M	-20.96M	-7.72M	-16.5M	-8.91M
Depreciation & Amortization - CF	405K	691K	1.03M	895K	551K
Amortization of Goodwill and Intangible Assets - (CF)	311K	311K	311K	311K	182K
Depreciation & Amortization, Total	715K	1M	1.34M	1.21M	732K
Amortization of Deferred Charges, Total - (CF)	17.5K	18.46K	-	1K	2.38K
(Gain) Loss From Sale Of Asset	-27.28K	-	-	-	-766K
(Gain) Loss on Sale of Investments - (CF)	-268K	227K	-	-	-
Asset Writedown & Restructuring Costs	-	13.18M	1.07M	7.56M	4.77M
(Income) Loss On Equity Investments - (CF)	714K	-	-	-	-
Stock-Based Compensation (CF)	699K	384K	14.2K	170K	-
Provision and Write-off of Bad Debts	105K	65.62K	-11.45K	-64.49K	12.7K
Other Operating Activities, Total	351K	90.76K	1.29M	2.16M	435K
Change In Accounts Receivable	-215K	1.45M	511K	397K	1.08M
Change In Inventories	513K	-89.52K	-332K	580K	1.02M
Change In Accounts Payable	685K	-1.28M	-545K	494K	574K
Change In Income Taxes	72	-72	0	1.04K	-1.04K
Cash from Operations	-3.82M	-5.91M	-4.39M	-4M	-1.06M
Capital Expenditure	-430K	-168K	-62.18K	-47.43K	-
Sale of Property, Plant, and Equipment	27.28K	37.79K	152K	-	1.22M
Cash Acquisitions	3.31M	-1.11M	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-10M	-	-	-	-
Other Investing Activities, Total	265K	92.29K	36.59K	-	-
Cash from Investing	-6.83M	-1.15M	127K	-47.43K	1.22M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-87.92K	-133K	-235K	-258K	-145K
Total Debt Repaid	-87.92K	-133K	-235K	-258K	-145K
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-92.75K	-221K	-175K	-	-
Other Financing Activities, Total	-9.66K	-	-	-	-8.59K
Cash from Financing	-190K	-354K	-410K	-258K	-154K
Foreign Exchange Rate Adjustments	-9.6K	36.62K	14.77K	811	-11.76K
Net Change in Cash	-10.85M	-7.38M	-4.66M	-4.3M	-10.16K
Supplemental Items
Cash Interest Paid	9.66K	-	-	-	252K
Cash Income Tax Paid (Refund)	-	-	-	-	15.25K
Levered Free Cash Flow	-5.03M	-3.79M	-2.31M	-2.86M	1.03M
Unlevered Free Cash Flow	-5.02M	-3.79M	-2.28M	-2.84M	1.18M
Change In Net Working Capital	1.87M	62.34K	-862K	-1.42M	-3.28M
Net Debt Issued / Repaid	-87.92K	-133K	-235K	-258K	-145K

Fiscal Period: October	2021	2022	2023	2024	2025
Profitability
Return on Assets	-8.57	-10.01	-12.38	-22.78	-21.77
Return on Total Capital	-8.99	-10.7	-13.39	-25.57	-28.9
Return On Equity %	-15.41	-45.58	-23.74	-76.58	-92.17
Return on Common Equity	-15.41	-45.58	-23.74	-76.58	-92.17
Margin Analysis
Gross Profit Margin %	-0.91	12.43	7.54	40.92	25.25
SG&A Margin	160.46	216.07	147.43	193.81	157.67
EBITDA Margin %	-145.94	-179.69	-119.18	-183.49	-116.92
EBITA Margin %	-153.83	-195.67	-133.77	-198.71	-129.42
EBIT Margin %	-161.37	-203.64	-139.9	-205.86	-134.83
Income From Continuing Operations Margin %	-172.66	-537.79	-152.43	-380.06	-265.13
Net Income Margin %	-172.66	-537.79	-152.43	-380.06	-265.13
Net Avail. For Common Margin %	-172.66	-537.79	-152.43	-380.06	-265.13
Normalized Net Income Margin	-110.3	-120.98	-81.92	-128.6	-91.02
Levered Free Cash Flow Margin	-122.12	-97.36	-45.64	-65.95	30.56
Unlevered Free Cash Flow Margin	-121.92	-97.15	-44.97	-65.31	35.08
Asset Turnover
Asset Turnover	0.08	0.08	0.14	0.18	0.26
Fixed Assets Turnover	0.39	0.2	0.26	0.29	0.38
Receivables Turnover (Average Receivables)	3.63	3.62	6.62	6.2	5.46
Inventory Turnover (Average Inventory)	1.72	0.97	1.31	0.9	1.45
Short Term Liquidity
Current Ratio	7.32	5.12	3.99	1.77	0.74
Quick Ratio	6.37	3.85	2.63	0.81	0.47
Operating Cash Flow to Current Liabilities	-1.15	-1.81	-1.65	-1.32	-0.3
Days Sales Outstanding (Average Receivables)	100.66	100.77	55.17	59.04	66.87
Days Outstanding Inventory (Average Inventory)	212.67	377.98	278.78	404.97	251.93
Average Days Payable Outstanding	82.08	129.17	111.57	172.59	208.42
Cash Conversion Cycle (Average Days)	231.25	349.58	222.37	291.42	110.38
Long Term Solvency
Total Debt/Equity	0.06	1.92	1.37	1.38	1.41
Total Debt / Total Capital	0.06	1.88	1.36	1.36	1.39
LT Debt/Equity	0	1.27	0.61	0.62	0.2
Long-Term Debt / Total Capital	0	1.25	0.6	0.61	0.2
Total Liabilities / Total Assets	5.56	9.47	8.78	18.59	38.53
EBIT / Interest Expense	-517.7	-596.78	-131.32	-202.31	-18.63
EBITDA / Interest Expense	-461.96	-521.43	-106.54	-175.02	-15.62
(EBITDA - Capex) / Interest Expense	-495.5	-534.05	-107.7	-176.1	-15.62
Total Debt / EBITDA	-0.01	-0.1	-0.07	-0.02	-0.02
Net Debt / EBITDA	2.89	1.31	0.82	0.08	0.19
Total Debt / (EBITDA - Capex)	-0.01	-0.1	-0.07	-0.02	-0.02
Net Debt / (EBITDA - Capex)	2.69	1.28	0.81	0.08	0.19
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-24.4	-5.31	29.96	-14.28	-22.6
Gross Profit, 1 Yr. Growth %	-102.93	-1.4K	-21.2	320.47	-52.25
EBITDA, 1 Yr. Growth %	-16.97	16.58	-13.8	32.18	-50.68
EBITA, 1 Yr. Growth %	-14.98	20.44	-11.15	27.34	-49.59
EBIT, 1 Yr. Growth %	-12.32	19.49	-10.72	26.14	-49.31
Earnings From Cont. Operations, 1 Yr. Growth %	-4.36	194.93	-63.16	113.73	-46.01
Net Income, 1 Yr. Growth %	-4.36	194.93	-63.16	113.73	-46.01
Normalized Net Income, 1 Yr. Growth %	-2.18	3.86	-12	34.57	-45.22
Diluted EPS Before Extra, 1 Yr. Growth %	-11.32	160.55	-62.64	116.68	-46.01
Accounts Receivable, 1 Yr. Growth %	7.07	-16.68	-32.67	27.38	-43.1
Inventory, 1 Yr. Growth %	70.3	31.79	-21.99	-18.95	-63.54
Net Property, Plant and Equip., 1 Yr. Growth %	717.64	1.94	-3.36	-41.19	-40.83
Total Assets, 1 Yr. Growth %	60.62	-34.27	-17.69	-48.15	-44.65
Tangible Book Value, 1 Yr. Growth %	20.99	-17.33	-16.7	-53.59	-57.65
Common Equity, 1 Yr. Growth %	57.36	-36.89	-17.2	-53.73	-58.21
Cash From Operations, 1 Yr. Growth %	30.99	54.37	-25.79	-7.84	-73.49
Capital Expenditures, 1 Yr. Growth %	55.44	-61	-62.96	-23.71	-
Levered Free Cash Flow, 1 Yr. Growth %	167.45	-24.51	-39.08	23.87	-135.86
Unlevered Free Cash Flow, 1 Yr. Growth %	172.26	-24.55	-39.84	24.49	-141.57
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-14.35	-15.39	10.93	5.55	-18.55
Gross Profit, 2 Yr. CAGR %	-77.93	-38.32	219.86	91.5	41.7
EBITDA, 2 Yr. CAGR %	77.62	-1.62	0.24	6.66	-19.26
EBITA, 2 Yr. CAGR %	81.52	1.19	3.45	6.37	-19.88
EBIT, 2 Yr. CAGR %	85.92	2.35	3.29	6.12	-20.04
Earnings From Cont. Operations, 2 Yr. CAGR %	2.08	67.95	4.23	-11.27	7.42
Net Income, 2 Yr. CAGR %	2.08	67.95	4.23	-11.27	7.42
Normalized Net Income, 2 Yr. CAGR %	54.6	0.8	-4.4	8.82	-14.14
Diluted EPS Before Extra, 2 Yr. CAGR %	-30.4	52	-1.33	-10.02	8.16
Accounts Receivable, 2 Yr. CAGR %	-2.08	-5.55	-27.56	-7.39	-14.86
Inventory, 2 Yr. CAGR %	37.83	49.82	1.39	-20.48	-45.63
Net Property, Plant and Equip., 2 Yr. CAGR %	177.92	193.08	-0.75	-24.61	-41.01
Total Assets, 2 Yr. CAGR %	18.27	2.83	-26.5	-34.67	-46.43
Tangible Book Value, 2 Yr. CAGR %	4.44	0.59	-17.02	-37.82	-55.67
Common Equity, 2 Yr. CAGR %	21.61	-0.35	-27.71	-38.1	-56.02
Cash From Operations, 2 Yr. CAGR %	45.29	42.44	7.03	-17.77	-50.57
Capital Expenditures, 2 Yr. CAGR %	5.33	-22.14	-61.99	-46.84	-
Levered Free Cash Flow, 2 Yr. CAGR %	41.03	42.1	-32.18	-13.13	-33.35
Unlevered Free Cash Flow, 2 Yr. CAGR %	33.52	43.32	-32.63	-13.46	-28.06
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-20.99	-11.44	-2.38	1.8	-4.82
Gross Profit, 3 Yr. CAGR %	-74.28	-14.17	-33.08	262.45	20.53
EBITDA, 3 Yr. CAGR %	147.57	54.36	-5.86	9.87	-17.52
EBITA, 3 Yr. CAGR %	154.16	58.32	-3.1	10.87	-17.07
EBIT, 3 Yr. CAGR %	158.25	60.44	-2.2	10.4	-17.04
Earnings From Cont. Operations, 3 Yr. CAGR %	118.15	45.39	1.29	32.42	-24.81
Net Income, 3 Yr. CAGR %	118.15	45.39	1.29	32.42	-24.81
Normalized Net Income, 3 Yr. CAGR %	120.35	35.4	-3.66	7.14	-13.43
Diluted EPS Before Extra, 3 Yr. CAGR %	68.52	8.06	-4.78	28.25	-24.11
Accounts Receivable, 3 Yr. CAGR %	-4.3	-7.21	-17.48	-12.56	-21.27
Inventory, 3 Yr. CAGR %	12.84	35.79	20.53	-5.9	-38.68
Net Property, Plant and Equip., 3 Yr. CAGR %	228.52	100.95	102.47	-16.64	-30.46
Total Assets, 3 Yr. CAGR %	105.01	-2.71	-4.58	-34.57	-38.18
Tangible Book Value, 3 Yr. CAGR %	468.05	-3.02	-5.54	-31.63	-45.3
Common Equity, 3 Yr. CAGR %	528.72	-2.28	-6.32	-37.7	-45.7
Cash From Operations, 3 Yr. CAGR %	31.14	48.42	14.61	1.44	-43.62
Capital Expenditures, 3 Yr. CAGR %	174.94	-24.36	-39.22	-52.05	-
Levered Free Cash Flow, 3 Yr. CAGR %	-	14.51	7.14	-17.1	-35.32
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	10.39	7.31	-17.33	-32.22
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-9.5	-5	-9.2
Gross Profit, 5 Yr. CAGR %	-	-	-29.5	18.32	-7.8
EBITDA, 5 Yr. CAGR %	-	-	72.44	33.15	-11.49
EBITA, 5 Yr. CAGR %	-	-	77.4	35.03	-10.2
EBIT, 5 Yr. CAGR %	-	-	79	35.99	-9.77
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	62.35	19.33	3.7
Net Income, 5 Yr. CAGR %	-	-	62.35	19.33	3.7
Normalized Net Income, 5 Yr. CAGR %	-	-	57.78	24.07	-8
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	36.04	0.43	0.2
Accounts Receivable, 5 Yr. CAGR %	-	-	-14.38	-8.51	-16.44
Inventory, 5 Yr. CAGR %	-	-	8.11	9.62	-12.34
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	104.76	35.76	23.63
Total Assets, 5 Yr. CAGR %	-	-	36.05	-17.06	-24.25
Tangible Book Value, 5 Yr. CAGR %	-	-	163.77	-18.82	-30.2
Common Equity, 5 Yr. CAGR %	-	-	164.66	-18.59	-30.77
Cash From Operations, 5 Yr. CAGR %	-	-	20.99	17.19	-18.31
Capital Expenditures, 5 Yr. CAGR %	-	-	24.59	-34.32	-
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	2.53	-11.39
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	0.15	-8.55